特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
939911

泌尿生殖器科分野での提携:2010年~2020年の世界的な契約のトレンド、関連組織、財務

Global Genitourinary Partnering 2010-2020: Deal trends, players and financials

出版日: | 発行: Current Partnering, a division of Wildwood Ventures Limited | ページ情報: 英文 350+ Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
泌尿生殖器科分野での提携:2010年~2020年の世界的な契約のトレンド、関連組織、財務
出版日: 2020年06月01日
発行: Current Partnering, a division of Wildwood Ventures Limited
ページ情報: 英文 350+ Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートは、2010年から2020年の世界の泌尿生殖器科分野における提携について調査したもので、契約締結のトレンド、財務面の条件、主な契約と関連組織、契約文書の要覧、治療対象別の契約などの情報を提供しています。

目次

エグゼクティブサマリー

第1章 - イントロダクション

第2章 -契約のトレンド

  • イントロダクション
  • 長期的な提携
  • 契約タイプ別の提携
  • 業界セクター別の提携
  • 開発段階別の提携
  • 技術タイプ別の提携
  • 治療適応別の提携

第3章 財務面の条件

  • イントロダクション
  • 開示された財務面の条件
  • 主な金額
  • 先行支払
  • マイルストーンペイメント
  • ライセンス料

第4章 -主な契約と関連組織

  • イントロダクション
  • 活発な動きのある提携
  • 活発な動きのある組織
  • 金額の大きな契約

第5章 -契約文書要覧

  • イントロダクション
  • 契約文書が入手可能な提携

第6章 -治療対象別の契約

  • イントロダクション
  • 治療対象別の契約

付録

目次
Product Code: CP2208

‘The Global Genitourinary Partnering 2010 to 2020: Deal trends, players and financials report’ provides comprehensive understanding and unprecedented access to the genitourinary partnering deals and agreements entered into by the worlds leading healthcare companies.

‘Global Genitourinary Partnering 2010 to 2020’ provides the full collection of Genitourinary disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

  • Trends in Genitourinary partnering deals
  • Financial deal terms for headline, upfront and royalty by stage of development
  • Genitourinary partnering agreement structure
  • Genitourinary partnering contract documents
  • Top Genitourinary deals by value
  • Most active Genitourinary dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Genitourinary disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Genitourinary deals.

The report presents financial deal terms values for Genitourinary deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Genitourinary dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Genitourinary dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Genitourinary deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Genitourinary dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Genitourinary deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Genitourinary partnering deals by specific Genitourinary target announced since 2010. The chapter is organized by specific Genitourinary therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Genitourinary partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Genitourinary partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Genitourinary technologies and products.

Report scope

‘Global Genitourinary Partnering 2010 to 2020’ is intended to provide the reader with an in-depth understanding and access to Genitourinary trends and structure of deals entered into by leading companies worldwide.

‘Global Genitourinary Partnering 2010 to 2020’ includes:

  • Trends in Genitourinary dealmaking in the biopharma industry since 2010
  • Analysis of Genitourinary deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Genitourinary deal contract documents
  • Comprehensive access to over 500 Genitourinary deal records
  • The leading Genitourinary deals by value since 2010
  • Most active Genitourinary dealmakers since 2010

The report includes deals for the following indications: Discharge, Frequency, Incontinence, Itching, Nocturia, Urgency, Acute kidney injury, Amyloidosis, Chronic kidney disease (CKD), Cystitis, Diabetic nephropathy, Dialysis, Hemolytic-uremic syndrome (HUS), Kidney stones, Nephrotic syndrom, Overactive bladder, Peyronie's disease, Polycystic kidney disease, Prostate diseases, Prostatitis, Prostate enlargement, Renal failure, Renal infections, Nephritis, Glomerulonephritis, Pyelonephritis, Vesicoureteral reflux, Urinary tract infection (UTI), plus other genitourinary indications.

In ‘Global Genitourinary Partnering 2010 to 2020’, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

‘The Global Genitourinary Partnering 2010 to 2020 report’ provides comprehensive access to available deals and contract documents for over 500 Genitourinary deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise Genitourinary rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

‘Global Genitourinary Partnering 2010 to 2020’ provides the reader with the following key benefits:

  • In-depth understanding of Genitourinary deal trends since 2010
  • Access Genitourinary deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between Genitourinary partner companies
  • Comprehensive access to over 500 links to actual Genitourinary deals entered into by the world's biopharma companies
  • Indepth review of Genitourinary deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner Genitourinary opportunities
  • Uncover companies actively partnering Genitourinary opportunities

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Genitourinary dealmaking

  • 2.1. Introduction
  • 2.2. Genitourinary partnering over the years
  • 2.3. Genitourinary partnering by deal type
  • 2.4. Genitourinary partnering by industry sector
  • 2.5. Genitourinary partnering by stage of development
  • 2.6. Genitourinary partnering by technology type
  • 2.7. Genitourinary partnering by therapeutic indication

Chapter 3 -Financial deal terms for Genitourinary partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for Genitourinary partnering
  • 3.3. Genitourinary partnering headline values
  • 3.4. Genitourinary deal upfront payments
  • 3.5. Genitourinary deal milestone payments
  • 3.6. Genitourinary royalty rates

Chapter 4 - Leading Genitourinary deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in Genitourinary partnering
  • 4.3. List of most active dealmakers in Genitourinary
  • 4.4. Top Genitourinary deals by value

Chapter 5 - Genitourinary contract document directory

  • 5.1. Introduction
  • 5.2. Genitourinary partnering deals where contract document available

Chapter 6 - Genitourinary dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by Genitourinary therapeutic target

Appendices

  • Appendix 1 - Directory of Genitourinary deals by company A-Z 2010 to 2020
  • Appendix 2 - Directory of Genitourinary deals by deal type 2010 to 2020
  • Appendix 3 - Directory of Genitourinary deals by stage of development 2010 to 2020
  • Appendix 4 - Directory of Genitourinary deals by technology type 2010 to 2020
  • Further reading on dealmaking
  • Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent report titles from CurrentPartnering

Table of figures

  • Figure 1: Genitourinary partnering since 2010
  • Figure 2: Genitourinary partnering by deal type since 2010
  • Figure 3: Genitourinary partnering by industry sector since 2010
  • Figure 4: Genitourinary partnering by stage of development since 2010
  • Figure 5: Genitourinary partnering by technology type since 2010
  • Figure 6: Genitourinary partnering by indication since 2010
  • Figure 7: Genitourinary deals with a headline value
  • Figure 8: Genitourinary deals with upfront payment values
  • Figure 9: Genitourinary deals with milestone payment
  • Figure 10: Genitourinary deals with royalty rates
  • Figure 11: Active Genitourinary dealmaking activity- 2010 to 2020
  • Figure 12: Top Genitourinary deals by value since 2010
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.